Search Result

15th American Drug Delivery & Formulation Summit We're excited to join the 15th American Drug Delivery & Formulation Summit on September 15-16, 2025 at Booth #30 — bringing our expertise in solid-state research, preformulation, and formulat...
Clinical and Commercial Manufacturing We provide flexible and reliable OSD manufacturing services using versatile technologies to address your formulation challenges.
Amorphous Solid Dispersions Amorphous solid dispersions have been shown to alter the properties of an API, including solubility, dissolution, and bioavailability. A variety of polymers or additives are available, and screening i...
Careers Our talented employees are an asset to our company and are the key to our continued success.We create an unlimited stage for employees to apply their skills and realize their potentials while contribu...
Crystal Pharmatech Returned to AAPS 2022 PharmSci 360 Crystal Pharmatech returned to the American Association of Pharmaceutical Scientists (AAPS) 2022 PharmSci 360 conference alongside pharmaceutical industry players, buyers, and suppliers.
GMP Manufacturing Crystal Pharmatech offers a full spectrum of formulation manufacturing services covering a wide variety of dosage forms and meeting GMP requirements in the US, Europe and China.
Unlock Solubility Enhancement Methods for Poorly Soluble Oral Drugs Oral solid drugs are widely used in the pharmaceutical industry due to good stability, cost-effectiveness, and convenient portability and administration. Oral drug absorption relies on dissolution as ...
FIH-PMF-FMF Manufacturing First-in-human (FIH) formulation development is done for phase I-IIa CTM Manufacturing to advance FIH clinical trial and obtain proof of concept (POC) of the safety and efficacy of the molecule under ...
BIO International Convention We're Heading to BIO2025 in Boston! Crystal Pharmatech is excited to announce our participation in the BIO International Convention from June 16-19 in Boston! Our senior leadership team from CRO...
Mol2Med™ Developability Assessment: Material-Sparing, Rapid Studies, and Developability Strategies
Contact Us
Crystal Pharmatech and Particle Sciences Form a US-China Pharmaceutical CRO Partnership By Damain GardeFrom Fierce BiotechPRINCETON, N.J. & SUZHOU, China--Crystal Pharmatech, a technology-driven solid-state research contract research organization (CRO) based in Suzhou, China, announc...